Bold Therapeutics Inc.

Bold Therapeutics Inc.

Biotechnology Research Ca 20 employees
Employees
20
Contacts
3
Emails
3

Bold Therapeutics Inc. Overview

Headquarters
Ca
Phone Number
Available in AeroLeads
Industry
Biotechnology Research
Employees
20
Founded
2018
Funding
796.6K
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Bold Therapeutics Inc.

Bold Therapeutics is the world leader in the development of novel metallotherapeutics. Bold Therapeutics' lead program, BOLD-100, has demonstrated positive safety and efficacy in Phase 2 clinical trials in colorectal, biliary tract and gastric cancers, with presentations at ASCO 2024 and ASCO GI 2024. Bold Therapeutics expects to initiate pivotal Phase 3 trials in the near future.

Bold Therapeutics Inc. Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage

Bold Therapeutics Inc. Org Chart

Sample employees and titles
Name Title Contact
Michelle A. Jones Sr. Director, Clinical Development
Email
Soumeya Abed
Email
Russell Mcallister President and CEO at Bold Therapeutics
View
Hooshmand Sheshbaradaran COO - Member Board Directors
Email

Employees by Management Level

Executive 2 profiles
VP / Head 1 profile
Director 1 profile
Manager 1 profile
Individual contributor 1 profile
Associate / junior 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 1 1 0
Healthcare 1 1 0

Compare Similar Companies to Bold Therapeutics Inc.